Nanobiotix Cash Flow Statement Analysis

Operating, investing, and financing activities in millions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Nanobiotix S.A. (NBTX) - Annual data in millions EUR
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-68.13-39.70-57.04-47.00-33.59-50.92-30.35
Depreciation & Amortization1.621.511.501.561.751.770.00
Deferred Income Tax0.100.120.000.000.000.000.00
Stock Based Compensation4.303.223.173.202.920.000.00
Change in Working Capital14.289.922.304.98-5.76-1.521.08
Change in Accounts Receivable-2.07-0.81-0.100.06-0.050.000.00
Change in Accounts Payable1.968.682.91-0.28-1.000.000.00
Change in Other Working Capital2.200.4412.660.686.810.000.00
Other Operating Activities28.3815.7012.663.362.884.970.50
Net Cash from Operating Activities-19.55-12.48-37.10-29.87-27.54-41.17-25.99
Investing Activities
Capital Expenditures-0.850.34-0.090.240.11-1.09-0.42
Purchases of Investments0.000.000.00-0.010.000.000.00
Sales/Maturities of Investments0.00-0.010.000.00-0.01-0.020.58
Other Investing Activities-0.11-0.010.23-0.010.000.000.00
Net Cash from Investing Activities-0.96-0.350.14-0.24-0.11-1.460.07
Financing Activities
Debt Repayment-4.16-3.77-4.74-3.74-1.18-0.50-0.93
Common Stock Issued0.0060.150.00-0.35113.6530.840.06
Other Financing Activities-0.9860.150.00-0.35-11.05-1.440.00
Net Cash from Financing Activities-5.1446.77-5.65-5.18111.7741.4914.85
Summary
Effect of Forex Changes on Cash0.09-0.050.080.06-0.060.030.05
Net Change in Cash-25.5533.95-42.62-35.1783.99-1.14-11.06
Cash at Beginning of Period75.2841.3983.92119.1535.0936.2047.21
Cash at End of Period49.7475.2841.3978.91114.0935.0936.20
Free Cash Flow-20.40-12.81-37.20-30.11-27.65-42.61-26.49
Supplemental Disclosures
Interest Paid0.986.980.921.130.700.000.00
Income Taxes Paid0.060.010.000.000.000.000.00